- 专利标题： HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS
-
申请号： US15814927申请日： 2017-11-16
-
公开(公告)号： US20180086748A1公开(公告)日： 2018-03-29
- 发明人: Joerg BENTZIEN , Angela Kay BERRY , Todd BOSANAC , Michael Jason BURKE , Darren Todd DISALVO , Joshua Courtney HORAN , Shuang LIANG , Can MAO , Wang MAO , Yue SHEN , Fariba SOLEYMANZADEH , Renee M. ZINDELL
- 申请人： Boehringer Ingelheim International GmbH
- 主分类号： C07D417/08
- IPC分类号： C07D417/08 ; C07D417/06 ; C07D231/14 ; C07D417/02 ; C07D413/14 ; C07D405/14 ; C07D403/08 ; C07D403/06 ; C07D403/04 ; C07D401/14 ; C07D401/06 ; C07D401/04 ; C07D401/02 ; C07D277/56 ; C07D231/40 ; C07D231/38 ; C07D417/04
摘要：
The present invention encompasses compounds of the formula (I) wherein the groups A, Cy, X1 and Y are defined herein, which are suitable for the treatment of diseases related to BTK, process of making, pharmaceutical preparations which contain compounds and their methods of use.
公开/授权文献
- US10138229B2 Heteroaromatic compounds as BTK inhibitors 公开/授权日：2018-11-27
信息查询
